Position in BNTX
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$36,149,738
+$1,921,251 QoQ
Shares Held
388,498
+0.9% QoQ
Ownership
0.155%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#28
of 282 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LBP AM SA holds $68,103,102 across 9 Biotechnology names. BNTX ranks #1 (53.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BNTX |
BioNTech SE
This page
|
388,498 | $36,149,738 | |
| 2 | INCY |
Incyte Corp
|
95,697 | $10,848,211 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15,597 | $7,747,497 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,206 | $4,276,432 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
93,906 | $3,663,273 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
17,947 | $2,057,982 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,005 | $1,873,737 | |
| 8 | RPRX |
Royalty Pharma plc
|
22,589 | $1,266,565 |
All Filings in BNTX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,149,738 | 388,498 | Shares | Defined | 2026-07-24 | |
| 2026-03-31 | $34,228,487 | 385,109 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $35,089,196 | 368,584 | Shares | Defined | 2026-01-26 | |
| 2025-09-30 | $34,845,305 | 353,329 | Shares | Defined | 2025-10-31 | |
| 2025-06-30 | $32,523,390 | 305,470 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $27,793,424 | 305,221 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $28,820,006 | 252,918 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $29,435,125 | 247,833 | Shares | Defined | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||